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ABSTRACT Small angle neutron scattering (SANS) results revealed that contrary to most reports C9 is not a globular protein. Its radius of
gyration (Rg) at pH 8 and an ionic strength of 0.5 is 32.2 ± 1.4 A increasing to 35 A at physiologic ionic strength. In contrast, C8, which
has a 2.2-fold larger mass, has a similar Rg value [34.6 ± 1.6 A]. Calibration plots of Rg vs. M, indicate that native C8 is a spherical protein
whereas native C9 is elongated. From previous reports it was known that native C8 and C9 associate in solutions of low ionic strength.
SANS results confirmed this observation but also demonstrated that C8-C9 heterodimers are already formed at physiologic ionic
strength. The dimeric complex is globular [Rg = 40 ± 0.8 A] indicating that the proteins associate side-by-side rather than end-to-end. In
contrast, in presence of the drug Suramin, a potent inhibitor of the assembly of the C5b-9 complex, C9 forms a complex with twice the
molecular mass that is still elongated (Rg = 48.8 ± 0.8 A), suggesting that in this case the protein dimerizes end-to-end via a bridging
Suramin molecule.
INTRODUCTION
The studies of Kolb and co-workers established the cen-
tral role ofcomplement proteins C5, C6, C7, C8, and C9
in the formation of the cytolytic C5b-9 complex, also
known as the membrane attack complex (MAC) of
complement ( 1, 2). A key observation in these early stud-
ies was the finding that these proteins, in their native
form, would interact with each other provided that the
ionic strength ofthe solution was much less than physio-
logical. Using sedimentation rate centrifugation in su-
crose density gradients it was found that C8 would inter-
act with C5 and C9 but not with C6 or C7, C9 would
interact only with C8, and C6 and C7 only with C5 but
not with each other. From such an interaction pattern
Kolb et al. (2) concluded that the MAC had the follow-
ing subunit structure:
C6-C5-C7
C8
carried out at reduced ionic strength in order to observe
the interactions. Apparently the binding constants for
the formation ofthese protein pairs at physiological con-
ditions are too low to withstand the force generated dur-
ing centrifugation. We have now used small angle neu-
tron scattering (SANS) to study the interaction between
C8 and C9 under physiological conditions. This method
has the advantage that no extraneous forces are present
during the experiment that might perturb weak protein-
protein interactions. Furthermore, the technique allows
detection of molecular shape changes as a result ofcom-
plex formation that are otherwise difficult to observe (9,
10). We have limited our study to C8-C9 interactions
since these two proteins are responsible for the cytolytic
function of the complex, and more importantly, it has
been postulated that C9 doubles in length after it binds
to C8 on a membrane and enters the hydrophobic lipid
bilayer (11). A preliminary account of this work has
been presented ( 12).
C9
These results were verified by Sodetz and colleagues (3-
5) who also established that the C8a chain interacts with
C9 and the C8,B chain with C5 and that the binding site
on C5 for C8,B is located on the C5b fragment. Using
analytical ultracentrifugation Podack et al. (6) deter-
mined a one-to-one stoichiometry for the C8-C9 interac-
tion in solution, which was an important observation
since multiple C9 molecules can be present in the mem-
brane-bound C5b-9 complex (7). C8a and C9 are Ca2"
binding proteins, however, the interaction between the
two proteins is not dependent on the presence of the
ion (8).
A caveat inherent in interpreting the results from all
these studies is the fact that the experiments had to be
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MATERIALS AND METHODS
Proteins. Human C8 and C9 were purified either from Cohn Fraction
III (Cutter Laboratories) or from ACD plasma as described by Esser
and Sodetz ( 13). C9 was also isolated from plasma as described but
substituting the final hydroxyapatite chromatography step in the C9
isolation procedure with ion exchange chromatography on FPLC
Mono S and Mono Q columns (Pharmacia, Piscataway, NJ) and keep-
ing 0.5 mM Ca2" ions in all buffers. C9 and C8a are calcium-binding
proteins (8) and especially C9 is more stable in the presence of Ca2"
ions ( 14). All protein solutions, however, were gel filtered on Sephacryl
S-200 equilibrated with 10 mM Mops, 150 mM NaCl, pH 7.0 just
before the SANS studies. Both proteins were better than 99% pure
based on SDS PAGE analysis and staining with Coomassie blue. C8
and C9 concentrations were determined by absorbance measurements
at 280 nm using extinction coefficients of e 1%/cm = 14.9 for C8 ande
1%/cm = 9.6 for C9 (13) and Mr values of 150,000 for C8 (13) and of
70,000 for C9 (13).
Neutron scattering. Small angle neutron scattering (SANS) experi-
ments were done on the Dl 1 camera ( 15 ) at the Institut Laue-Lange-
vin in Grenoble. Neutron wavelength, X, was 10 A with an 8% spread
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and sample detector distance was 2.8 m to give a Q range from 0.01 to
0.08 A-', where Q = 4r sin 0/X, and 0 is half the scattering angle.
Samples were contained in 1.00 mm path length quartz cuvettes
(Hellma, Jamaica, New York) thermostated at 6°C. Protein concen-
tration was determined by measuring the absorbance at 280 nm of the
protein solution in the same cuvettes used for SANS studies and the
measurements were repeated after the experiment to verify the absence
of solvent evaporation. Protein aggregation during the experiment was
assessed by comparing the ratio ofA250/A2M before and after the exper-
iment.
The intensity, I(Q), of neutrons scattered by the protein particles in
solution was obtained from the sample scattering after subtraction of
the buffer contribution and was corrected for detector response and put
on an absolute scale by normalizing by the incoherent scattering of 1.00
mm of H20 (16). The neutron scattering contrast radius of gyration,
Rg, and forward scattered intensity, I(0), were obtained from the I(Q)
data at the smaller Q values, by applying the Guinier approximation
(17):
ln I(Q) = ln I(0) - ('/3)R 2Q2.
Data were plotted as ln I(Q) vs. Q2 and straight lines were fitted to
the chosen Q range by least squares. Typical Q ranges corresponded to
0.5 < QRg < 2. The molar massM [g/mol] ofthe solution particle was
calculated from the I(0)/c values (where c is protein concentration in
mg/ml) by using the formula given in Jacrot and Zaccai (16), and the
scattering length per mole of protein was calculated from its chemical
composition. In the case of a polydisperse solution of particles of the
same chemical composition, the apparent molar mass, M, calculated
from I(0)/c is given by: M = c,M, + c2M2 + c3M3 + * * *, where there
are c, [mg/ml] of particles of molar mass M,, c2 of M2, etc.
RESULTS
SANS data were collected from protein solutions in H20
buffers with concentrations close to 1 mg/ml. This is the
smallest concentration possible for SANS studies and no
studies were performed at lower concentrations. Under
these conditions, the weak signal to noise ratio did not
allow measurements to be made beyond Q of about 3 /
Rg, and only two parameters (M and Rg), calculated
from the Guinier plots, could be determined. Neverthe-
less, these are two extremely useful independent quanti-
ties, because they are obtained on an absolute scale and
they are very sensitive to the size and shape of the solu-
tion particles and therefore oftheir interactions. Further-
more, because of the very small coherent scattering of
H20, the analysis on an absolute scale is insensitive to
assumptions concerning the partial specific volumes of
the particles ( 16). The hydrodynamic analogy is that of
an experiment in vacuum, in which there is no buoyancy
term.
Table I lists the Rg andM values calculated for human
C9 and C8 under different environmental conditions
and Fig. 1 shows some ofthe recorded experimental data
from which the tabulated values were calculated. TheM
values are in excellent agreement with molecular weight
determinations for C8 and C9 using other techniques.
For example, molecular weight values for monomeric
C9 range from 79,000 as determined from SandD ( 18),
to 70,000 ± 5,000 measured by light scattering ( 19), and
the value calculated from the amino acid sequence and
TABLE 1 Radius of gyration and molecular mass of C8 and C9
Protein pH A Addition Rg [A] M [Da]
C8 8.0 0.5 34.6 ± 0.5 150,000 ± 2,100
C8 8.0 0.16 35.5 ± 0.4 176,000 ± 2,000
C9 8.0 0.5 32.2 ± 1.4 73,900 ± 3,800
C9 8.0 0.16 35.2 ± 1.6 73,600 ± 3,300
C9 8.0 0.16 Suramin 42.8 ± 1.0 155,900 ± 4,000
C8 + C9 8.0 0.16 39.9 ± 0.8 206,700 ± 5,200
C8 + C9 8.0 0.5 34.4 ± 0.7 126,400 ± 2,500
C8 7.2 0.16 37.1 ± 0.5 221,000 ± 2,500
C9 7.2 0.16 38.1 ± 1.3 75,600 ± 3,100
C9 7.2 0.16 Suramin 48.8 ± 0.8 187,000 ± 3,300
C8 + C9 7.2 0.16 40.9 ± 0.6 242,500 ± 3,800
the amount ofN-linked sugars is 66,000 ( 1). There are
also 0-linked sugars in C9 but the total amount is not
known ( 11). Careful sedimentation equilibrium centrif-
ugation yields an Mr value of 70,000 ± 3,000 (Esser and
Nagel, unpublished results). Previous molecular weight
values for C8 are all very close to 150,000; for example,
Sodetz and colleagues reported 151,000 ± 8,000 by sedi-
mentation equilibrium ultracentrifugation (20) and the
value calculated from the amino acid composition and
the amount of N-linked sugars (21 ) is 146,240.
From the work of Tschopp and Masson (22) it is
known that the polyanionic drug Suramin inhibits for-
mation ofthe MAC. Inclusion of 10-fold molar excess of
Suramin to C9 solutions results in an increase ofRg to 43
A and a doubling ofM, indicating that C9 forms a dimer
under these conditions (Table 1 and Fig. 2). When C8
and C9 are mixed in buffers of physiological ionic
strength they form a one to one complex with a mass of
about 207 kD and complex formation is inhibited when
the ionic strength is raised to 0.5 (Table 1 and Fig. 3).
Surprisingly, there is only a small increase in the radius
of gyration for the C8-C9 complex and the complex re-
mains globular (Fig. 4). Dialysis ofC9 into D20 buffers
results in severe aggregation of the protein (Fig. 5).
DISCUSSION
The molecular weights of C9 and C8 as determined by
SANS are in excellent agreement with previously pub-
lished values using different techniques. Therefore, con-
sidering the large difference in mass between the two
proteins it is striking that they have the same radius of
gyration at pH 8 and physiological ionic strength, that is
35.5 + 0.4 and 35.2 ± 1.6 A, respectively. Both proteins
appear to become slightly more compact at higher ionic
strength since these values decrease to 34.6 ± 0.5 A and
32.2 ± 1.4 A. Thus, C9 is not a compact globular protein.
This interpretation is corroborated by results from a suf-
ficient number of SANS studies on other globular pro-
teins. As was pointed out by Zaccai and colleagues (23),
for globular proteins a good correlation exists between
M, and R., that is, a doubling ofRg requires an approxi-
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NEUTRON SCATTERING OF NATIVE C8 AND C9
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FIGURE I Neutron scattering data plotted in the Guinier approximation for native C8 (0) at 1.6mg/ml and C9 (*) at 1.2mg/ml at 6°C, in 10mM
Mops, 150 mM NaCl buffer, pH 7.0. See text for further experimental conditions.
mate five fold increase in Mr, and one can construct a
"calibration" curve relating Mr to Rg for globular pro-
teins (Fig. 4). Based on this correlation one can classify
C8 as a globular protein. This conclusion is unexpected
since C8 is a three chain protein consisting of a, ,B and y
polypeptides with molecular masses of64, 64, and 22 kD
that are made from different genes (21 ). Multisubunit
proteins of this size are mostly not globular. In contrast,
the single chain C9 protein, which has frequently been
considered to be a globular protein, is unquestionably
elongated. Monomeric C9 is thought to elongate when it
enters a membrane during formation of the MAC (11,
19, 24). Our results raise the possibility that such
changes might be far less drastic than had been envi-
sioned previously.
More parameters could have been calculated from
I(Q) to larger Q values (25), but for such data to be
reliable, protein concentrations of -10 mg/ml are re-
quired. Unfortunately, C9 protein solutions were aggre-
gated beyond about 2 mg/ml in agreement with many
other studies that reported a tendency ofC9 to polymer-
ize when concentrated (26-28). Our own previous stud-
ies had shown that C9 aggregation is retarded at higher
ionic strength (8) and at higher pH (14) and for these
reasons most studies were performed at pH 8, and statis-
tically the most reliable Rg value for C9 was obtained at
an ionic strength of -0.5.
Another useful approach would have been to study
proteins in D20 buffers, in which the signal to noise ratio
is greatly enhanced (29). The problem with such studies,
however, is the fact that D20 stabilizes hydrophobic in-
teractions and thereby can promote protein aggregation.
This was observed for many ofthe complement proteins
studied thus far and was now encountered likewise for
C9 (Fig. 5), making this approach very hazardous. In
this respect our data on C9 differ significantly from those
reported by Perkins and colleagues (30, 31 ). They report
SANS data obtained for C9 in 100% D2O and at protein
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FIGURE 2 Guinier plots for native C9 (1.4 mg/ml) with (*) and without (O) a 10-fold molar excess of Suramin in 10 mM Mops, 150 mM NaCl
buffer, pH 8.0.
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C8-C9 INTERACTIONS
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FIGURE 3 Guinier plots for equimolar mixtures of C8 and C9 in (O, A) 10 mM Mops, 150 NaCl, pH 8.0 buffer or in (*) 10 mM Mops, 150mM
NaCl, 200 mM Na2SO4, pH 8.0 buffer.
concentrations as high as 7.6 mg/ml. Our C9 prepara-
tions could not be concentrated to more than 2 mg/ml
and substitution ofH20 with D20 resulted in immediate
aggregation of C9. We used several techniques, such as
slow dialysis of C9 into D20 buffers, or quick exchange
using spinner columns, exchange at room temperature
or at 4°C, but none were successful and C9 could not be
examined in D20 buffers. This result is not too surpris-
ing since C9 is known to be amphipathic (28) and the
hydrophobic character ofthe protein would be enhanced
in D20. The reason for these differences between our
data and those ofSmith et al. (31 ) is unknown, although
a major difference is the inclusion of 1 mM EDTA in the
buffers used by them. Therefore, while it is clear that
their values are representative ofthe apo-protein and not
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FIGURE 4 Dependency of the radii of gyration on their molecular
wights. The line (R3 = constant X Mr) in logarithmic coordinates is for
globular proteins (0) such as ribonuclease (Rg = 13; Mr = 13,900),
lysozyme (Rg= 14; Mr= 14,300), papain (Rg= 16; Mr = 23,000) and
hemoglobin (Rg =23.5; Mr =64,500). For further details see reference
(23).
the native, Ca-containing protein, it is, however, doubt-
ful that 1 mM EDTA would be able to prevent C9 aggre-
gation either at high protein concentration or in D20
buffers. It is known that EDTA causes formation of C9
aggregates (28) or tubular polymerized C9 at higher pro-
tein concentration (27). Smith et al. (31 ) indicate that
their protein was -95% pure whereas we could not de-
tect impurities in the C9 preparations used for this work
on Coomassie blue-stained SDS polyacrylamide gels. It
may be possible that unknown impurities prevented C9
association in their experiments. In the present study,
therefore, we interpreted the M and Rg values from dif-
ferent solutions of - 1 mg/ml of protein, all in H20
buffers and with well defined pH and salt content, and
we have refrained from modeling studies aimed at pro-
viding molecular details of proteins that are beyond the
resolution ofthe technique and the accuracy ofthe exper-
imental data.
How the three C8 subunits combine to form a globular
protein remains an interesting question especially con-
NEUTRON SCATTERING OF C9 IN D20
-1.01
0.0 1.0 2.0 3.0 4.0
Q2 (103 X A-2)
5.0 6.0
FIGURE 5 Guinier plots for C9 (1.2 mg/ml) in a D20 buffer contain-
ing 10 mM Mops, 150 mM NaCl, pD 7.0.
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sidering the fact that C8 a, C8 1, and C9 are evolutionary
closely related polypeptides. One would expect them to
have a similar three dimensional folding since they share
a mosaic structure in the sense that they are made from
similar domains or modules:
C8a: NH2-T-L-(lb)-G-T-COOH
C8#: NH2-T-L-(lb)-G-T-COOH
C9: NH2-T-L-(lb)-G-COOH.
The nomenclature for these modules (T, L, G) was of-
fered by Baron et al. (32) who also proposed that the
structure of such domains is preserved in different pro-
teins; (lb) is a putative lipid binding domain but not
necessarily a module.
Even more intriguing is the fact that when C9 asso-
ciates with C8 the resulting complex remains globular
(Fig. 4). Careful experiments by Sodetz and colleagues
(3-5) revealed that in solution C9 has an affinity only for
C8a and not for C81 nor C8y. This result together with
the observation that the C8-C9 dimer is globular would
indicate that C8 is in close contact with C9 along the
latter's longer axis otherwise the dimer would not be glob-
ular. At higher ionic strength C8 and C9 do not associate
as indicated by the fact that Rg is unchanged and that the
measured mass corresponds to the mass proportions of
the two proteins in the solution (Fig. 3 and Table 1).
Previously, the association of C8 and C9 could only be
observed at reduced ionic strength, but based on the
ionic strength dependency of the interaction, Stewart
and Sodetz (4) proposed that the two proteins should be
in association under physiological conditions and our
SANS studies confirm this prediction. This is not a triv-
ial result since some of the intermediates formed during
MAC assembly, for example, C5b or C5b-7 have only a
very short lifetime and they must find another reaction
partner, such as C6 or a membrane, in a short time.
Association of C8 and C9 under physiological condi-
tions, and by analogy, the other proteins that form the
MAC, assures that they can interact much more effi-
ciently as would be otherwise possible.
The absence ofmultimers (Fig. 3) also indicates that a
SANS study of the C8-C9 complex might be possible at
higher protein concentrations that is otherwise not feasi-
ble because of the tendency of C9 to aggregate. This
would allow a more precise modeling ofthe dimer struc-
ture using Debye spheres (25). A second possibility to
elucidate the structure of C9 more precisely by SANS
could come from the use of Suramin at pH 8. This drug
interacts strongly with terminal complement proteins
(22) and as our results indicate the compound produces
a complex with twice the mass of monomeric C9 and
again there is no indication of higher protein aggregates.
Suramin is a symmetrical molecule with a hydrophobic
aromatic core and two negatively charged naphthalene
trisulfonate side chains. Thus, it is most likely that there
is only one binding site per C9 for Suramin and that two
C9 molecules are bridged by Suramin via the negatively
charged sulfonates. Since the resulting dimer remains
elongated (Fig. 4), the most plausible structure is an
end-to-end rather than a side-to-side association of the
two C9 molecules.
In summary, our results indicate that C8 is a globular
protein while C9 is not and that the two proteins asso-
ciate under physiological conditions. They also provide
evidence that a future neutron scattering study ofC8-C9
heterodimers and ofC9 dimers formed in the presence of
Suramin at larger scattering angles and at higher protein
concentration might allow a more precise modeling of
the solution structure of these proteins.
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